Christiana Stamoulis, SVP, Corporate Strategy & Business Devlp at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 57,698 shares at $77.88 ($4.6M) on 2013-04-30, disclosed to the SEC on 2013-05-01.
Scheduled sale ($4.6M) by SVP, Corporate Strategy & Business Devlp under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $79.69 | 57,697 | $4.6M | 100.0% |
| 2 | $77.88 | 1 | $78 | 0.0% |
| Total | $79.69 avg | 57,698 | $4.6M | 100% |
| Filing → |
| HOLX | SELL | 2020-11-06 | $825K | — | Filing → |
| HOLX | SELL | 2019-11-26 | $1.2M | — | Filing → |
| HOLX | SELL | 2018-11-30 | $1.2M | — | Filing → |